JPI, Madera Residential, and WayMaker Announce Five-Deal Joint Venture
The three companies will partner to provide 1,750+ class A multifamily homes to residents across…
The three companies will partner to provide 1,750+ class A multifamily homes to residents across…
Upcoming ISG Provider Lens™ reports will evaluate providers enabling intelligent, AI-powered automation for modernizing and…
First Facility in the Region to Offer Clinical Storage, Packaging and Distribution Will Fuel Job…
MINNEAPOLIS–(BUSINESS WIRE)–Northstar Capital (“Northstar”), a provider of junior capital for middle market private equity transactions,…
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA assigns preliminary ratings to five classes of notes issued by Carvana Auto…
OLDWICK, N.J.–(BUSINESS WIRE)–AM Best has revised the outlooks to stable from negative and affirmed the…
CHIASSO, Switzerland & BOSTON–(BUSINESS WIRE)–Board International, the global leader for Intelligent Planning for leading enterprises…
OLDWICK, N.J.–(BUSINESS WIRE)–AM Best has affirmed the Financial Strength Rating of A- (Excellent) and the…
As used originations increase, credit unions reach nearly 26% total vehicle financing market share, the…
Josh Stella examines how organizations must adapt to the ever-changing cloud security threat landscape FREDERICK,…
Internationally renowned health system to unify data across systems to improve access to healthcare in…
Battery Electric Vehicles to Fuel Growth BOSTON–(BUSINESS WIRE)–The push to electric vehicles is being dictated…
Major new agreement to power Bally’s Interactive brands with market-leading data and streaming solutions Genius…
Redgate Software announced today that Microsoft will be the Premier Sponsor of the 2022 PASS…
Sofwave to host showcase booth from September 1-4 Facial and neck treatment workshop held on…
PRINCETON, N.J., Aug. 25, 2022 (GLOBE NEWSWIRE) — Oyster Point Pharma, Inc. (Nasdaq: OYST), a…
Issued claims will protect use of a biomarker to assess response to Lomecel-B™ in patients…
SOUTH SAN FRANCISCO, Calif., Aug. 25, 2022 (GLOBE NEWSWIRE) — Catalyst Biosciences, Inc. (NASDAQ: CBIO)…
Abelacimab is the only Factor XI inhibitor currently being evaluated in Phase 3 trials The…
SOUTH SAN FRANCISCO, Calif., Aug. 25, 2022 (GLOBE NEWSWIRE) — Frontier Medicines Corporation, a precision…